Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Helicobacter pylori eradication in children with non-alcoholic fatty liver disease
PACTR202212783625379Not yet recruiting
- Sponsor
- Alexandria University
- Start
- Dec 2022
- Countries
- 1
01
Overview
Open-label trial in Helicobacter pylori infection and metabolic dysfunction-associated steatotic liver disease (MASLD) (2 arms), sponsored by Alexandria University. Primary endpoint: Hepatic steatosis. Planned start Dec 2022; status: not yet recruiting.
02
Conditions
Helicobacter pylori infectionmetabolic dysfunction-associated steatotic liver disease (MASLD)
Beyond the preview
Go deeper on PACTR202212783625379.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202212783625379.